Cargando…

The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient

BACKGROUND: Spectrum effects refer to the phenomenon that test performance varies across subgroups of a population. When spectrum effects occur during diagnostic testing for cancer, difficult patient misdiagnoses can occur. Our objective was to evaluate the effect of test indication, age, gender, ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopalakrishna, Ajay, Longo, Thomas A., Fantony, Joseph J., Owusu, Richmond, Foo, Wen-Chi, Dash, Rajesh, Inman, Brant A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906712/
https://www.ncbi.nlm.nih.gov/pubmed/27296150
http://dx.doi.org/10.1186/s12894-016-0147-5
_version_ 1782437456817160192
author Gopalakrishna, Ajay
Longo, Thomas A.
Fantony, Joseph J.
Owusu, Richmond
Foo, Wen-Chi
Dash, Rajesh
Inman, Brant A.
author_facet Gopalakrishna, Ajay
Longo, Thomas A.
Fantony, Joseph J.
Owusu, Richmond
Foo, Wen-Chi
Dash, Rajesh
Inman, Brant A.
author_sort Gopalakrishna, Ajay
collection PubMed
description BACKGROUND: Spectrum effects refer to the phenomenon that test performance varies across subgroups of a population. When spectrum effects occur during diagnostic testing for cancer, difficult patient misdiagnoses can occur. Our objective was to evaluate the effect of test indication, age, gender, race, and smoking status on the performance characteristics of two commonly used diagnostic tests for bladder cancer, urine cytology and fluorescence in situ hybridization (FISH). METHODS: We assessed all subjects who underwent cystoscopy, cytology, and FISH at our institution from 2003 to 2012. The standard diagnostic test performance metrics were calculated using marginal models to account for clustered/repeated measures within subjects. We calculated test performance for the overall cohort by test indication as well as by key patient variables: age, gender, race, and smoking status. RESULTS: A total of 4023 cystoscopy-cytology pairs and 1696 FISH-cystoscopy pairs were included in the analysis. In both FISH and cytology, increasing age, male gender, and history of smoking were associated with increased sensitivity and decreased specificity. FISH performance was most impacted by age, with an increase in sensitivity from 17 % at age 40 to 49 % at age 80. The same was true of cytology, with an increase in sensitivity from 50 % at age 40 to 67 % at age 80. Sensitivity of FISH was higher for a previous diagnosis of bladder cancer (46 %) than for hematuria (26 %). Test indication had no impact on the performance of cytology and race had no significant impact on the performance of either test. CONCLUSIONS: The diagnostic performance of urine cytology and FISH vary significantly according to the patient demographic in which they were tested. Hence, the reporting of spectrum effects in diagnostic tests should become part of standard practice. Patient-related factors must contextualize the clinicians’ interpretation of test results and their decision-making.
format Online
Article
Text
id pubmed-4906712
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49067122016-06-15 The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient Gopalakrishna, Ajay Longo, Thomas A. Fantony, Joseph J. Owusu, Richmond Foo, Wen-Chi Dash, Rajesh Inman, Brant A. BMC Urol Research Article BACKGROUND: Spectrum effects refer to the phenomenon that test performance varies across subgroups of a population. When spectrum effects occur during diagnostic testing for cancer, difficult patient misdiagnoses can occur. Our objective was to evaluate the effect of test indication, age, gender, race, and smoking status on the performance characteristics of two commonly used diagnostic tests for bladder cancer, urine cytology and fluorescence in situ hybridization (FISH). METHODS: We assessed all subjects who underwent cystoscopy, cytology, and FISH at our institution from 2003 to 2012. The standard diagnostic test performance metrics were calculated using marginal models to account for clustered/repeated measures within subjects. We calculated test performance for the overall cohort by test indication as well as by key patient variables: age, gender, race, and smoking status. RESULTS: A total of 4023 cystoscopy-cytology pairs and 1696 FISH-cystoscopy pairs were included in the analysis. In both FISH and cytology, increasing age, male gender, and history of smoking were associated with increased sensitivity and decreased specificity. FISH performance was most impacted by age, with an increase in sensitivity from 17 % at age 40 to 49 % at age 80. The same was true of cytology, with an increase in sensitivity from 50 % at age 40 to 67 % at age 80. Sensitivity of FISH was higher for a previous diagnosis of bladder cancer (46 %) than for hematuria (26 %). Test indication had no impact on the performance of cytology and race had no significant impact on the performance of either test. CONCLUSIONS: The diagnostic performance of urine cytology and FISH vary significantly according to the patient demographic in which they were tested. Hence, the reporting of spectrum effects in diagnostic tests should become part of standard practice. Patient-related factors must contextualize the clinicians’ interpretation of test results and their decision-making. BioMed Central 2016-06-13 /pmc/articles/PMC4906712/ /pubmed/27296150 http://dx.doi.org/10.1186/s12894-016-0147-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gopalakrishna, Ajay
Longo, Thomas A.
Fantony, Joseph J.
Owusu, Richmond
Foo, Wen-Chi
Dash, Rajesh
Inman, Brant A.
The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
title The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
title_full The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
title_fullStr The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
title_full_unstemmed The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
title_short The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
title_sort diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906712/
https://www.ncbi.nlm.nih.gov/pubmed/27296150
http://dx.doi.org/10.1186/s12894-016-0147-5
work_keys_str_mv AT gopalakrishnaajay thediagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT longothomasa thediagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT fantonyjosephj thediagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT owusurichmond thediagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT foowenchi thediagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT dashrajesh thediagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT inmanbranta thediagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT gopalakrishnaajay diagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT longothomasa diagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT fantonyjosephj diagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT owusurichmond diagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT foowenchi diagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT dashrajesh diagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient
AT inmanbranta diagnosticaccuracyofurinebasedtestsforbladdercancervariesgreatlybypatient